Drugs / Levonorgestrel / Ethinyl Estradiol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06071442 | Jan → Apr 2024 | — | Alexion Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Levonorgestrel / Ethinyl Estradiol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06071442 ↗ |
| Route | Oral | “Participants will receive oral tablets of Levonorgestrel/ Ethinyl Estradiol.” NCT06071442 ↗ |